Dissociation during esketamine therapy tied to better outcomes in treatment-resistant depression

Patients with treatment-resistant depression who reported feelings of unreality or dissociation during subcutaneous esketamine therapy were more likely to see their depressive symptoms improve, according to a new study. The findings suggest dissociation may be linked to the drug's antidepressant effectiveness rather than being merely an unwanted side effect.